Abstract:(Cell Stem Cell 4, 16–19; January 9, 2009) In our recent article, we unfortunately misquoted the findings in a recent study by Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar. When describing previous work using combination of the MEK inhibitor PD0325901 and the GSK3b inhibitor CHIR99021, our statement “Recent studies demonstrated that addition of the FGFR inhibitor PD173074 to the above cocktail is sufficient to maintain mESC pluripotency in the absence of LIF (Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar).” was not accurate. Ying et al., in fact, used PD0325901 to replace PD1730474 and demonstrated maintenance of mESCs in the absence of LIF with these two factors only. The corrected section reads “Indeed, after serial passages, the growth of putative riPSCs treated with only PD0325901 and CHIR99021 declined, and the culture deteriorated due to the expansion of differentiated cells, although recent studies demonstrated that this combination of inhibitors can be used to maintain mESC self-renewal in the absence of LIF (Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar). Because the TGFβ/Activin A/Nodal signaling cascade is essential to maintain undifferentiated hESCs and EpiSCs, but dispensable for mESC self-renewal, we tested whether the addition of an inhibitor of the type 1 TGFβ receptor, ALK5 (A-83-01), could help stabilize our riPSC cultures.” In addition, we omitted to mention that while our study was under review, Silva et al., 2008Silva J. Barrandon O. Nichols J. Kawaguchi J. Theunissen T.W. Smith A. Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition.PLoS Biol. 2008; 6: 2237-2247https://doi.org/10.1371/journal.pbio.0060253Crossref Scopus (651) Google Scholar also published the use of these two inhibitors in the generation and propagation of mouse iPSCs. We apologize for any confusion caused. Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical InhibitorsLi et al.Cell Stem CellDecember 18, 2008In BriefConventional mouse and human embryonic stem cells (ESCs) can be typically derived by in vitro culture of blastocysts (Martin, 1981; Thomson et al., 1998), and induced pluripotent stem cells (iPSCs) can be generated by reprogramming somatic cells using defined genetic transduction methods (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007). In both cases, different signaling pathways appear to regulate pluripotency with different characteristics in the two species. However, while rat ESC-like cells have been established based on certain traits (Demers et al., 2007; Ruhnke et al., 2003; Schulze et al., 2006; Ueda et al., 2008), to date, these lines fall short of exhibiting true pluripotency (e.g., fail to form teratoma or no/little contribution to chimerism) and thus cannot be considered authentic rat ESCs. Full-Text PDF Open Archive

Generation of Pulmonary Endothelial Progenitor Cells for Cell-based Therapy Using Interspecies Mouse-Rat Chimeras

Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: Open-label pilot study

Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.

Endothelial Progenitor Cell-Based Therapy for Pulmonary Arterial Hypertension

Generation of functional lungs via conditional blastocyst complementation using pluripotent stem cells

Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors

Endothelial progenitor cells stimulate neonatal lung angiogenesis through FOXF1-mediated activation of BMP9/ACVRL1 signaling

Generation of rat blood vasculature and hematopoietic cells in rat-mouse chimeras by blastocyst complementation

Microfluidic Single-Cell Analysis Shows That Porcine Induced Pluripotent Stem Cell-Derived Endothelial Cells Improve Myocardial Function by Paracrine Activation

Generation of rat-derived lung epithelial cells in Fgfr2b-deficient mice retains species-specific development

Pulmonary Transplantation of Human Induced Pluripotent Stem Cell-derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis

CRISPR-Cas9 Genome Editing Allows Generation of the Mouse Lung in a Rat

In Vivo Reprogramming of Mouse Fibroblasts into Cardiac Progenitor Cells for Myocardial Infarction Treatment

Efficient Derivation of Basal Progenitor Cells from Human Pluripotent Stem Cells for Modeling Esophageal Development

Using Human Pluripotent Stem Cell Differentiated Endothelial Cells to Study the Differential Regulation in PAH

Derivation of Endothelial Cells from Porcine Induced Pluripotent Stem Cells by Optimized Single Layer Culture System.

Repopulation Efficiencies of Adult Hepatocytes, Fetal Liver Progenitor Cells, and Embryonic Stem Cell-Derived Hepatic Cells in Albumin-Promoter-enhancer Urokinase-Type Plasminogen Activator Mice.

The Differentiation of Pluripotent Stem Cells Towards Endothelial Progenitor Cells - Potential Application in Pulmonary Arterial Hypertension.

Abstract 210: Reprogramming Mouse Fibroblasts Into Cardiac Progenitor Cells Using Crispr Technique Targeting Endogenic Genes

Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates

Efficient Generation of Lung and Airway Epithelial Cells from Human Pluripotent Stem Cells